Lv1
58 积分 2025-08-26 加入
Gasdermin D pore structure reveals preferential release of mature interleukin-1
3天前
已完结
Neuroprotection of GLP-1/GIP receptor agonist via inhibition of mitochondrial stress by AKT/JNK pathway in a Parkinson's disease model
3个月前
已完结
Discovery of New Difluorocyclobutyl Derivatives as Effective Glucagon-Like Peptide-1 Receptor Agonists with Reduced hERG Inhibitory Activities
3个月前
已完结
Therapeutic application of GLP-1 and GIP receptor agonists in Parkinson’s disease
3个月前
已完结
Discovery and Proof of Concept of Potent Dual Polθ/PARP Inhibitors for Efficient Treatment of Homologous Recombination-Deficient Tumors
3个月前
已完结
First-Time Disclosure of CVN424, a Potent and Selective GPR6 Inverse Agonist for the Treatment of Parkinson’s Disease: Discovery, Pharmacological Validation, and Identification of a Clinical Candidate
3个月前
已完结
The microbiome–gut–brain axis in Parkinson disease — from basic research to the clinic
3个月前
已完结
Pyridine-to-Pyridazine Skeletal Editing
3个月前
已完结
Dehydrogenative Cyclization of 2-Aminobenzyl Alcohols with Ketones or Secondary Alcohols to Construct Quinolines
3个月前
已完结
Strengths, Weaknesses, Opportunities, and Potential Threat Analysis of Targeting Leucine-Rich Repeat Kinase 2 for Parkinson’s Disease Treatment: Status Quo and Quo Vadis
3个月前
已完结
皖公网安备34019202002308
